Thyroid Eye Disease
Symptoms, Doctors, Treatments, Advances & More

Thyroid Eye Disease Overview

Save information for later
Sign Up

Learn About Thyroid Eye Disease

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Thyroid Eye Disease Local Doctors?
Elite in Thyroid Eye Disease
Endocrinology
Elite in Thyroid Eye Disease
Endocrinology

MN - Cancer

200 1st St SW, 
Rochester, MN 
Languages Spoken:
English

Marius Stan is an Endocrinologist in Rochester, Minnesota. Dr. Stan is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Graves Disease, Hyperthyroidism, Thyroid Eye Disease, Thyroidectomy, and Ureteroscopy.

Elite in Thyroid Eye Disease
Endocrinology
Elite in Thyroid Eye Disease
Endocrinology

Office

300 Pasteur Dr, 
Stanford, CA 
Languages Spoken:
English
Offers Telehealth

Chrysoula Dosiou is an Endocrinologist in Stanford, California. Dr. Dosiou is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. Her top areas of expertise are Thyroid Eye Disease, Graves Disease, Hyperthyroidism, and Thyroid Cancer.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Thyroid Eye Disease
Ophthalmology
Elite in Thyroid Eye Disease
Ophthalmology

Raymond Douglas M.D. PhD A Professional Corp.

9675 Brighton Way Ste 410, 
Beverly Hills, CA 
Languages Spoken:
English

Raymond Douglas is an Ophthalmologist in Beverly Hills, California. Dr. Douglas is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Thyroid Eye Disease, Graves Disease, Eyelid Drooping, and Ptosis.

What are the latest Thyroid Eye Disease Clinical Trials?
A Multicenter Phase 2b Randomized, Double-Masked, Placebo-Controlled Dose-Ranging Study of TOUR006 in Participants With Thyroid Eye Disease

Summary: Phase 2b trial of TOUR006 in Thyroid Eye Disease (TED) to evaluate 20mg and 50mg doses against placebo given by a subcutaneous injection every eight weeks to TED patients who are in the active inflammatory phase of disease.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects With Moderate-to-Severe Active Thyroid Eye Disease

Summary: The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of this study is to investigate the efficacy of AMG 732 in participants with Thyroid Eye Disease (TED) after multiple SC doses.